HER2-positive apocrine carcinoma of the breast: a population-based analysis of incidence, treatment, and outcome

被引：0
|
作者：
Skenderi, F. [1 ]
Alahmad, M. A. M. [1 ]
Alahmad, Y. M. [1 ]
Abdelhafez, I. H. E. [1 ]
Gatalica, Z. [1 ]
Vranic, S. [1 ]
机构：
[1] Qatar Univ, QU Hlth, Coll Med, Doha, Qatar
来源：
VIRCHOWS ARCHIV | 2020年 / 477卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-063
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
    Skenderi, Faruk
    Alahmad, Mohamad Alhoda Mohamad
    Tahirovic, Emin
    Alahmad, Yaman M.
    Gatalica, Zoran
    Vranic, Semir
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (02) : 523 - 533
  • [2] HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
    Faruk Skenderi
    Mohamad Alhoda Mohamad Alahmad
    Emin Tahirovic
    Yaman M. Alahmad
    Zoran Gatalica
    Semir Vranic
    [J]. Breast Cancer Research and Treatment, 2022, 193 : 523 - 533
  • [3] Treatment of HER2-positive cutaneous apocrine carcinoma of the axilla
    Kamata, Arimichi
    Hino, Koji
    Matsuda, Arisa
    Kamiyama, Koki
    Takasaka, Yoshihiro
    Tazawa, Kenichi
    [J]. INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024,
  • [4] HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast
    Kito, Katsumi
    Maeda, Toshiharu
    Ninomiya, Keiko
    Sugita, Atsuro
    Sagawa, Teiri
    Matsuoka, Kinya
    Kinoshita, Kousei
    Hyodo, Naoki
    Morita, Nagisa
    Furuya, Keizo
    [J]. CASE REPORTS IN PATHOLOGY, 2014, 2014
  • [5] Treatment of HER2-positive breast cancer
    Figueroa-Magalhaes, Maria Cristina
    Jelovac, Danijela
    Connolly, Roisin M.
    Wolff, Antonio C.
    [J]. BREAST, 2014, 23 (02): : 128 - 136
  • [6] Meningeal carcinomatosis of HER2-positive Breast Carcinoma
    Preusser, M.
    Berghoff, A.
    Furtner, J.
    Dieckmann, D.
    Bartsch, R.
    [J]. TUMORBOARD, 2013, 2 (01): : 15 - 16
  • [7] The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study
    Yiqun Han
    Yun Wu
    Hangcheng Xu
    Jiayu Wang
    Binghe Xu
    [J]. International Journal of Clinical Oncology, 2022, 27 : 707 - 716
  • [8] The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study
    Han, Yiqun
    Wu, Yun
    Xu, Hangcheng
    Wang, Jiayu
    Xu, Binghe
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (04) : 707 - 716
  • [9] A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer
    Christine Brezden-Masley
    Kelly E. Fathers
    Megan E. Coombes
    Behin Pourmirza
    Cloris Xue
    Katarzyna J. Jerzak
    [J]. Breast Cancer Research and Treatment, 2021, 185 : 807 - 815
  • [10] A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer
    Brezden-Masley, Christine
    Fathers, Kelly E.
    Coombes, Megan E.
    Pourmirza, Behin
    Xue, Cloris
    Jerzak, Katarzyna J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (03) : 807 - 815
12345